Enhanced HSP70Â lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B

Nature Communications

Volumn 3, Issue , 2012, Pages

  Cho, Hyun Soo ^a   Shimazu, Tadahiro ^b   Toyokawa, Gouji ^a,c   Daigo, Yataro ^a,d   Maehara, Yoshihiko ^c   Hayami, Shinya ^a   Ito, Akihiro ^b   Masuda, Ken ^a   Ikawa, Noriko ^a   Field, Helen I ^e   Tsuchiya, Eiju ^f,g   Ohnuma, Shin Ichi ^h   Ponder, Bruce A J ^e   Yoshida, Minoru ^b   Nakamura, Yusuke ^a,i   Hamamoto, Ryuji ^a,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f SAITAMA CANCER CENTER   (Japan)

^g KANAGAWA CANCER CENTER   (Japan)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA B KINASE; HEAT SHOCK PROTEIN 70; LYSINE; AURORA KINASE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CANCER CELL; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; IMMUNOPRECIPITATION; METABOLISM; METHYLATION; PROTEIN BINDING; TISSUE MICROARRAY; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LYSINE; METHYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; TISSUE ARRAY ANALYSIS;

EID: 84867026199     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2074     Document Type: Article

References (51)

1. Clarke, S. G. & Tamanoi, F. Protein Methyltransferases. The Enzymes Vol. XXIV, 3rd Edn. (Academic Press, San Diego, 2006).
2. Bedford, M. T. & Clarke, S. G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell. 33, 1-13 (2009).
3. McBride, A. E. & Silver, P. A. State of the arg: protein methylation at arginine comes of age. Cell 106, 5-8 (2001). (Pubitemid 32709951)
4. Lachner, M. & Jenuwein, T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14, 286-298 (2002). (Pubitemid 34626966)
5. Chuikov, S. et al. Regulation of p53 activity through lysine methylation. Nature 432, 353-360 (2004). (Pubitemid 39551664)
6. Huang, J. et al. Repression of p53 activity by Smyd2-mediated methylation. Nature 444, 629-632 (2006). (Pubitemid 44864441)
7. Cho, H. S. et al. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res. 71, 1-6 (2011).
8. Kunizaki, M. et al. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Cancer Res. 67, 10759-10765 (2007). (Pubitemid 350145903)
9. Kampinga, H . H. & Craig, E. A. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat. Rev. Mol. Cell Biol. 11, 579-592 (2010).
10. Guinez, C., Losfeld, M. E., Cacan, R., Michalski, J. C. & Lefebvre, T. Modulation of HSP70 GlcNAc-directed lectin activity by glucose availability and utilization. Glycobiology 16, 22-28 (2006). (Pubitemid 43009804)
11. Kumar, Y. & Tatu, U. Stress protein flux during recovery from simulated ischemia: induced heat shock protein 70 confers cytoprotection by suppressing JNK activation and inhibiting apoptotic cell death. Proteomics 3, 513-526 (2003). (Pubitemid 36428303)
12. Moore, D. J., West, A. B., Dikeman, D. A., Dawson, V. L. & Dawson, T. M. Parkin mediates the degradation-independent ubiquitination of Hsp70. J. Neurochem. 105, 1806-1819 (2008). (Pubitemid 351678490)
13. Muller, P. et al. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Oncogene (e-pub ahead of print 23 July 2012; doi:10.1038/onc.2012.314).
14. Iwabata, H., Yoshida, M. & Komatsu, Y. Proteomic analysis of organ-specific post-translational lysine-acetylation and-methylation in mice by use of anti-acetyllysine and-methyllysine mouse monoclonal antibodies. Proteomics 5, 4653-4664 (2005). (Pubitemid 43016886)
15. Quan, X., Tsoulos, P., Kuritzky, A., Zhang, R. & Stochaj, U. The carrier Msn5p/Kap142p promotes nuclear export of the hsp70 Ssa4p and relocates in response to stress. Mol. Microbiol. 62, 592-609 (2006). (Pubitemid 44477244)
16. Crosio, C. et al. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell Biol. 22, 874-885 (2002). (Pubitemid 34053065)
17. Prigent, C. & Dimitrov, S. Phosphorylation of serine 10 in histone H3, what for? J. Cell. Sci. 116, 3677-3685 (2003). (Pubitemid 37185297)
18. Vader, G., Medema, R. H. & Lens, S. M. The chromosomal passenger complex: guiding Aurora-B through mitosis. J. Cell. Biol. 173, 833-837 (2006).
19. Hsu, J. Y. et al. Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102, 279-291 (2000).
20. Jeyaprakash, A. A. et al. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 131, 271-285 (2007). (Pubitemid 47576137)
21. Ruchaud, S., Carmena, M. & Earnshaw, W. C. Chromosomal passengers: conducting cell division. Nat. Rev. Mol. Cell Biol. 8, 798-812 (2007). (Pubitemid 47462135)
22. Yasui, Y. et al. Autophosphorylation of a newly identified site of Aurora-B is indispensable for cytokinesis. J. Biol. Chem. 279, 12997-13003 (2004). (Pubitemid 38445876)
23. Lens, S. M., Voest, E. E. & Medema, R. H. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat. Rev. Cancer 10, 825-841 (2010).
24. Vader, G. & Lens, S. M. The Aurora kinase family in cell division and cancer. Biochim. Biophys. Acta 1786, 60-72 (2008).
25. Beardmore, V. A., Ahonen, L. J., Gorbsky, G. J. & Kallio, M. J. Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity. J. Cell. Sci. 117, 4033-4042 (2004). (Pubitemid 39328292)
26. Cooke, C. A., Heck, M. M. & Earnshaw, W. C. The inner centromere protein (INCENP) antigens: movement from inner centromere to midbody during mitosis. J. Cell. Biol. 105, 2053-2067 (1987). (Pubitemid 18019057)
27. Honda, R., Korner, R. & Nigg, E. A. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 14, 3325-3341 (2003). (Pubitemid 37013130)
28. Ellinger, J. et al. Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma. Int. J. Cancer 127, 2360-2366 (2010).
29. Elsheikh, S. E. et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69, 3802-3809 (2009).
30. Seligson, D. B. et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435, 1262-1266 (2005). (Pubitemid 40943093)
31. Meraldi, P., Honda, R. & Nigg, E. A. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr. Opin. Genet. Dev. 14, 29-36 (2004). (Pubitemid 38167474)
32. Katayama, H., Brinkley, W. R. & Sen, S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 22, 451-464 (2003). (Pubitemid 36791899)
33. Lok, W., Klein, R. Q. & Saif, M. W. Aurora kinase inhibitors as anti-cancer therapy. Anticancer Drugs 21, 339-350 (2010).
34. Galluzzi, L., Giordanetto, F. & Kroemer, G. Targeting HSP70 for cancer therapy. Mol. Cell 36, 176-177 (2009).
35. Li, Y. et al. Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers. Cancer Res. 70, 5695-5705 (2010).
36. Yadav, S., Singhal, J., Singhal, S. S. & Awasthi, S. hSET1: a novel approach for colon cancer therapy. Biochem. Pharmacol. 77, 1635-1641 (2009).
37. Hamamoto, R. et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell. Biol. 6, 731-740 (2004). (Pubitemid 39144478)
38. Hamamoto, R. et al. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci. 97, 113-118 (2006). (Pubitemid 43379478)
39. Kato, T. et al. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res. 65, 5638-5646 (2005). (Pubitemid 40911164)
40. Kikuchi, T. et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22, 2192-2205 (2003). (Pubitemid 36539569)
41. Taniwaki, M. et al. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int. J. Oncol. 29, 567-575 (2006).
42. Ishikawa, N. et al. ADAM8 as a novel serological and histochemical marker for lung cancer. Clin. Cancer Res. 10, 8363-8370 (2004). (Pubitemid 40053398)
43. Ishikawa, N. et al. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Res. 67, 11601-11611 (2007).
44. Cho, H. S. et al. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 13, 676-684 (2011).
45. Takawa, M. et al. Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Sci. 102, 1298-1305 (2011).
46. Toyokawa, G. et al. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6. Cancer Prev. Res. 4, 2051-61 (2011).
47. Toyokawa, G. et al. The histone lysine methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia 13, 887-898 (2011).
48. Toyokawa, G. et al. Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer. Mol. Cancer 10, 65 (2011).
49. Hayami, S. et al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int. J. Cancer 128, 574-586 (2011).
50. Hayami, S. et al. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol. Cancer 9, 59 (2010).
51. Yoshimatsu, M. et al. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int. J. Cancer 128, 562-573 (2011).